Annual Working Capital
$24.40 M
+$31.09 M+464.70%
December 31, 2023
Summary
- As of February 12, 2025, CTCX annual working capital is $24.40 million, with the most recent change of +$31.09 million (+464.70%) on December 31, 2023.
- During the last 3 years, CTCX annual working capital has risen by +$40.02 million (+256.15%).
- CTCX annual working capital is now at all-time high.
Performance
CTCX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$4.29 M
-$2.61 M-155.79%
September 30, 2024
Summary
- As of February 12, 2025, CTCX quarterly working capital is -$4.29 million, with the most recent change of -$2.61 million (-155.79%) on September 30, 2024.
- Over the past year, CTCX quarterly working capital has dropped by -$5.45 million (-469.96%).
- CTCX quarterly working capital is now -117.58% below its all-time high of $24.40 million, reached on December 31, 2023.
Performance
CTCX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CTCX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +464.7% | -470.0% |
| 3 y3 years | +256.1% | +35.9% |
| 5 y5 years | +256.1% | +35.9% |
CTCX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +256.1% | -117.6% | +35.9% |
| 5 y | 5-year | at high | +256.1% | -117.6% | +35.9% |
| alltime | all time | at high | +256.1% | -117.6% | +35.9% |
Carmell Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$4.29 M(+155.8%) |
| Jun 2024 | - | -$1.68 M(-2.3%) |
| Mar 2024 | - | -$1.72 M(-107.0%) |
| Dec 2023 | $24.40 M | $24.40 M(+2004.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.16 M(-128.7%) |
| Jun 2023 | - | -$4.05 M(-39.5%) |
| Dec 2022 | -$6.69 M(-57.2%) | -$6.69 M |
| Dec 2021 | -$15.62 M | - |
FAQ
- What is Carmell Therapeutics annual working capital?
- What is the all time high annual working capital for Carmell Therapeutics?
- What is Carmell Therapeutics annual working capital year-on-year change?
- What is Carmell Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly working capital year-on-year change?
What is Carmell Therapeutics annual working capital?
The current annual working capital of CTCX is $24.40 M
What is the all time high annual working capital for Carmell Therapeutics?
Carmell Therapeutics all-time high annual working capital is $24.40 M
What is Carmell Therapeutics annual working capital year-on-year change?
Over the past year, CTCX annual working capital has changed by +$31.09 M (+464.70%)
What is Carmell Therapeutics quarterly working capital?
The current quarterly working capital of CTCX is -$4.29 M
What is the all time high quarterly working capital for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly working capital is $24.40 M
What is Carmell Therapeutics quarterly working capital year-on-year change?
Over the past year, CTCX quarterly working capital has changed by -$5.45 M (-469.96%)